138 related articles for article (PubMed ID: 20234182)
1. The role of autophagy as a mechanism of cytotoxicity by the clinically used agent MDA-7/IL-24.
Lehman S; Koumenis C
Cancer Biol Ther; 2010 Apr; 9(7):537-8. PubMed ID: 20234182
[No Abstract] [Full Text] [Related]
2. OSU-03012 enhances Ad.7-induced GBM cell killing via ER stress and autophagy and by decreasing expression of mitochondrial protective proteins.
Hamed HA; Yacoub A; Park MA; Eulitt P; Sarkar D; Dimitrie IP; Chen CS; Grant S; Curiel DT; Fisher PB; Dent P
Cancer Biol Ther; 2010 Apr; 9(7):526-36. PubMed ID: 20107314
[TBL] [Abstract][Full Text] [Related]
3. Glioblastoma in a patient with a hereditary cancer syndrome.
Steckley JL; Watling CJ; Ng W
Can J Neurol Sci; 2008 Mar; 35(1):98-101. PubMed ID: 18380286
[No Abstract] [Full Text] [Related]
4. MRI characteristics and histological changes in glioblastoma after gene therapy.
Weber FW; Floeth FW; Reifenberger G; Felsberg J; Aulich A; Kiwit JC; Bock WJ
Front Radiat Ther Oncol; 1999; 33():244-52. PubMed ID: 10549494
[No Abstract] [Full Text] [Related]
5. Clonal diversity in glioblastoma: is it clinically relevant?
Watts C; Piccirillo SG
Future Oncol; 2015; 11(12):1703-6. PubMed ID: 26075436
[TBL] [Abstract][Full Text] [Related]
6. Studying a complex tumor: potential and pitfalls.
Zheng S; Chheda MG; Verhaak RG
Cancer J; 2012; 18(1):107-14. PubMed ID: 22290264
[TBL] [Abstract][Full Text] [Related]
7. Editorial: New Therapeutic Approaches for the Treatment of Glioblastoma.
Festuccia C; Gravina GL
Curr Cancer Drug Targets; 2017; 17(3):200-202. PubMed ID: 28322151
[No Abstract] [Full Text] [Related]
8. Peptide micelle-mediated delivery of tissue-specific suicide gene and combined therapy with avastin in a glioblastoma model.
Oh B; Han J; Choi E; Tan X; Lee M
J Pharm Sci; 2015 Apr; 104(4):1461-9. PubMed ID: 25631673
[TBL] [Abstract][Full Text] [Related]
9. Functional validation confirms genomic phenotypes of glioblastoma with implications for targeted therapy.
Parsa AT
World Neurosurg; 2011; 75(5-6):573-4. PubMed ID: 21704908
[No Abstract] [Full Text] [Related]
10. Tamoxifen improves cytopathic effect of oncolytic adenovirus in primary glioblastoma cells mediated through autophagy.
Ulasov IV; Shah N; Kaverina NV; Lee H; Lin B; Lieber A; Kadagidze ZG; Yoon JG; Schroeder B; Hothi P; Ghosh D; Baryshnikov AY; Cobbs CS
Oncotarget; 2015 Feb; 6(6):3977-87. PubMed ID: 25738357
[TBL] [Abstract][Full Text] [Related]
11. Glioblastoma therapy: going beyond Hercules Columns.
Mangiola A; Anile C; Pompucci A; Capone G; Rigante L; De Bonis P
Expert Rev Neurother; 2010 Apr; 10(4):507-14. PubMed ID: 20367204
[TBL] [Abstract][Full Text] [Related]
12. Genomics illuminates a deadly brain cancer.
Kuehn BM
JAMA; 2010 Mar; 303(10):925-7. PubMed ID: 20215599
[No Abstract] [Full Text] [Related]
13. Adenovirus expressing dual c-Met-specific shRNA exhibits potent antitumor effect through autophagic cell death accompanied by senescence-like phenotypes in glioblastoma cells.
Lee JS; Oh E; Yoo JY; Choi KS; Yoon MJ; Yun CO
Oncotarget; 2015 Feb; 6(6):4051-65. PubMed ID: 25726528
[TBL] [Abstract][Full Text] [Related]
14. Enhancement of glioblastoma radioresponse by a selective COX-2 inhibitor celecoxib: inhibition of tumor angiogenesis with extensive tumor necrosis.
Kang KB; Wang TT; Woon CT; Cheah ES; Moore XL; Zhu C; Wong MC
Int J Radiat Oncol Biol Phys; 2007 Mar; 67(3):888-96. PubMed ID: 17293239
[TBL] [Abstract][Full Text] [Related]
15. Glioblastoma Biology, Genetics and Possible Therapies.
Castresana JS; Meléndez B
Cells; 2023 Aug; 12(16):. PubMed ID: 37626873
[TBL] [Abstract][Full Text] [Related]
16. Glioblastoma, hypoxia and autophagy: a survival-prone 'ménage-à-trois'.
Jawhari S; Ratinaud MH; Verdier M
Cell Death Dis; 2016 Oct; 7(10):e2434. PubMed ID: 27787518
[TBL] [Abstract][Full Text] [Related]
17. Basic and Translational Advances in Glioblastoma.
Piccirillo SGM; Alonso MM; Pasqualetti F
Biomed Res Int; 2018; 2018():1820345. PubMed ID: 29780818
[No Abstract] [Full Text] [Related]
18. Rapid radiographic and clinical improvement after treatment of a MET-amplified recurrent glioblastoma with a mesenchymal-epithelial transition inhibitor.
Chi AS; Batchelor TT; Kwak EL; Clark JW; Wang DL; Wilner KD; Louis DN; Iafrate AJ
J Clin Oncol; 2012 Jan; 30(3):e30-3. PubMed ID: 22162573
[No Abstract] [Full Text] [Related]
19. Gene therapy in brain tumours: implications of the size of glioblastoma on its curability.
Izquierdo M; Cortés ML; Martín V; de Felipe P; Izquierdo JM; Pérez-Higueras A; Paz JF; Isla A; Blázquez MG
Acta Neurochir Suppl; 1997; 68():111-7. PubMed ID: 9233425
[TBL] [Abstract][Full Text] [Related]
20. Present trend in the primary treatment of aggressive malignant glioma: glioblastoma multiforme.
Parvez T
Technol Cancer Res Treat; 2008 Jun; 7(3):241-8. PubMed ID: 18473496
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
